Nielsen and Wolters Kluwer Health form alliance

Share this article:

In an effort to raise the bar on consumer health targeting, messaging and measurement, Nielsen and Wolters Kluwer Health have launched HealthScape, an information platform.

The platform touts “de-identified patient prescription-related transaction data,” courtesy of Wolters Kluwer Health, combined with “consumer purchasing, attitudinal and behavior information,” from Nielsen, according to a company release. Specifically, Nielsen will offer its consumer OTC and consumer packaged goods data from its Homescan and Scantrack services. Wolters Kluwer Health will provide data from its SourceLx and Pharmaceutical Audit Suite (PHAST) services.

Media buyers, for example, can use HealthScape's prescription drug data to assess ad executions with greater precision, according to Rick Crangle, national director at Wolters Kluwer Health. The same metrics used to calibrate and execute media plans for consumer products can now be employed to bring more accuracy and sophistication to prescription drug media efforts. Key factors for determining [pharmaceutical] ad placement vary by product and market, but include managed care, physician recommendations, race, age and gender,” said Crangle.

Factors driving patient purchasing patterns, which are measurable by HealthScape, include co-morbidities, severity of condition, type of insurance plan and impact of co-pay versus retail price, managed care formulary controls and mass media advertising, and others, according to Crangle. 

HealthScape products are available in both subscription report format or as ad hoc reports, and can be customized based on a client's needs, noted Crangle.

Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...